Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Enact Holdings, Inc. (Nasdaq: ACT) SEC filings, offering a detailed view of how the U.S. private mortgage insurance provider reports its financial condition, capital structure and material events. As a public company headquartered in Raleigh, North Carolina and operating through Enact Mortgage Insurance Corporation, Enact uses its filings to disclose information that is central to understanding its mortgage insurance business.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Enact’s discussion of primary insurance in-force, new insurance written, loss experience, capital sufficiency relative to Private Mortgage Insurer Eligibility Requirements, and the impact of reinsurance and credit facilities. Current reports on Form 8-K supplement these periodic filings by describing specific events, such as the announcement of quarterly financial results or the entry into a senior unsecured revolving credit facility.
Enact’s filings also include details on its credit risk transfer activities, including quota share and excess of loss reinsurance agreements with panels of highly rated reinsurers. These documents explain how portions of expected new insurance written for future book years are covered and how such arrangements affect risk and capital management. The credit agreement filed as an exhibit to an 8-K outlines the terms of the revolving credit facility, including financial covenants tied to consolidated net worth, debt-to-total capitalization and PMIERs compliance.
On Stock Titan, SEC documents for ACT are updated in near real time as they are posted to the EDGAR system. AI-powered summaries help interpret complex sections of 10-Ks, 10-Qs and 8-Ks by highlighting key points about earnings, capital, reinsurance structures and covenants. Users can also review insider and executive transaction reports on Form 4, along with proxy and governance filings, with AI-generated explanations that clarify how these disclosures relate to Enact’s mortgage insurance operations and its relationship with majority owner Genworth Financial, Inc.
RESTREPO ROBERT P JR reported acquisition or exercise transactions in this Form 4 filing.
Enact Holdings, Inc. director Robert P. Restrepo Jr. reported receiving 162 Deferred Stock Units on March 19, 2026 as a grant tied to a dividend reinvestment at $0.21 per share. These units are payable in shares of common stock one year after his service as a director ends, bringing his directly held deferred stock unit balance to 30,705.457.
Enact Holdings director Debra Still received 162 Deferred Stock Units as a grant tied to dividends. These units were acquired under the director award agreement through reinvestment of a cash dividend paid on March 19, 2026, at $0.21 per share. Following this grant, Still holds 30,705.457 Deferred Stock Units directly. The Deferred Stock Units are payable in shares of common stock one year after she terminates service as a director.
Enact Holdings EVP and Chief Risk Officer Michael Derstine reported routine equity compensation activity. On March 19, 2026, he received three small grants totaling 70 restricted stock units (RSUs), all at a stated price of $0.00 per unit, as part of existing award agreements.
Each RSU settles into one share of Enact common stock and vests in three equal annual installments, beginning on February 16, 2025, February 21, 2026, and February 13, 2027, respectively. Footnotes explain that some of these RSUs were acquired through dividend reinvestment tied to a quarterly dividend of $0.21 per share, paid on March 19, 2026.
Enact Holdings, Inc. executive vice president, general counsel and secretary Evan Stolove reported three small awards of restricted stock units on March 19, 2026. The RSUs each convert into common stock on a 1:1 basis and vest in three equal annual installments beginning on February 16, 2025, February 21, 2026, and February 13, 2027. A portion of the units reflects additional awards under dividend reinvestment terms tied to a quarterly dividend of $0.21 per share paid on March 19, 2026. These are routine compensation and reinvestment grants, and no shares were sold.
Enact Holdings director Dominic James Addesso received a grant of 281 Deferred Stock Units on Common Stock-equivalent terms. These units were awarded at a price of $0.00 per unit and increase his directly held deferred stock units to 9,293.163 units following the transaction.
According to the footnotes, the additional deferred stock units were acquired under the director award agreement through reinvestment of a dividend paid on March 19, 2026 at $0.21 per share. The deferred stock units become payable in shares of Enact Holdings Common Stock one year after termination of his service as a director.
THOMPSON WESTLEY V reported acquisition or exercise transactions in this Form 4 filing.
Enact Holdings director Westley V. Thompson received an automatic grant of 162 Deferred Stock Units on Common Stock-equivalent terms. These units were credited at a price of $0.21 per share under reinvestment terms tied to a dividend paid on March 19, 2026. Following this compensation-related award, Thompson directly holds a total of 30,705.457 Deferred Stock Units, which will be settled in shares of Common Stock one year after his termination of service as a director.
Enact Holdings director Elizabeth H. Mitchell reported an acquisition of 30 Deferred Stock Units linked to Enact common stock. These units were granted at a price of $0.00 per unit and increase her direct deferred stock unit balance to 5,718.256 units after the transaction.
According to accompanying notes, the additional deferred stock units were acquired under the director award agreement’s reinvestment terms from a dividend paid on March 19, 2026 at $0.21 per share. The deferred stock units become payable in shares of common stock one year after her termination of service as a director.
Enact Holdings director Michael A. Bless reported an acquisition of 139 Deferred Stock Units on Enact common stock. The units were added under a director award agreement through reinvestment of a cash dividend paid on March 19, 2026 at $0.21 per share. After this award, Bless holds 26,631.538 Deferred Stock Units, which become payable in Enact common shares one year after his termination of service as a director.
Enact Holdings, Inc. Controller James McMullen reported an open-market sale of 2,500 shares of common stock at $41.64 per share. After this transaction, he directly holds 1,272 Enact Holdings shares. The sale was executed through a series of broker-assisted trades at the same price.
ACT reported a Form 144 disclosing a sale of common stock. The filing shows 678 shares sold on 02/04/2026 by Suzanne Mcmullen for $29,832.00.
The excerpt also lists restricted stock vesting events with amounts and dates: 454 on 02/11/2024, 406 on 02/16/2025, 640 on 02/09/2026, 543 on 02/16/2026, and 457 on 02/21/2026.